
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Knockdown of GLP-1 Receptors in Vagal Afferents Affects Normal Food Intake and Glycemia
Jean‐Philippe Krieger, Myrtha Arnold, Klaus G. Pettersen, et al.
Diabetes (2015) Vol. 65, Iss. 1, pp. 34-43
Open Access | Times Cited: 221
Jean‐Philippe Krieger, Myrtha Arnold, Klaus G. Pettersen, et al.
Diabetes (2015) Vol. 65, Iss. 1, pp. 34-43
Open Access | Times Cited: 221
Showing 1-25 of 221 citing articles:
Glucagon-like peptide 1 (GLP-1)
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1306
Timo D. Müller, Brian Finan, Stephen R. Bloom, et al.
Molecular Metabolism (2019) Vol. 30, pp. 72-130
Open Access | Times Cited: 1306
Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
Daniel J. Drucker
Cell Metabolism (2018) Vol. 27, Iss. 4, pp. 740-756
Open Access | Times Cited: 1241
Daniel J. Drucker
Cell Metabolism (2018) Vol. 27, Iss. 4, pp. 740-756
Open Access | Times Cited: 1241
Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit
Zhuang Li, Chun‐Xia Yi, Saeed Katiraei, et al.
Gut (2017) Vol. 67, Iss. 7, pp. 1269-1279
Open Access | Times Cited: 547
Zhuang Li, Chun‐Xia Yi, Saeed Katiraei, et al.
Gut (2017) Vol. 67, Iss. 7, pp. 1269-1279
Open Access | Times Cited: 547
Anxiety, Depression, and the Microbiome: A Role for Gut Peptides
Gilliard Lach, Harriët Schellekens, Timothy G. Dinan, et al.
Neurotherapeutics (2017) Vol. 15, Iss. 1, pp. 36-59
Open Access | Times Cited: 489
Gilliard Lach, Harriët Schellekens, Timothy G. Dinan, et al.
Neurotherapeutics (2017) Vol. 15, Iss. 1, pp. 36-59
Open Access | Times Cited: 489
Ghrelin, CCK, GLP-1, and PYY(3–36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB
Robert E. Steinert, Christine Feinle‐Bisset, Lori Asarian, et al.
Physiological Reviews (2016) Vol. 97, Iss. 1, pp. 411-463
Open Access | Times Cited: 488
Robert E. Steinert, Christine Feinle‐Bisset, Lori Asarian, et al.
Physiological Reviews (2016) Vol. 97, Iss. 1, pp. 411-463
Open Access | Times Cited: 488
GLP-1 physiology informs the pharmacotherapy of obesity
Daniel J. Drucker
Molecular Metabolism (2021) Vol. 57, pp. 101351-101351
Open Access | Times Cited: 274
Daniel J. Drucker
Molecular Metabolism (2021) Vol. 57, pp. 101351-101351
Open Access | Times Cited: 274
Signaling pathways in obesity: mechanisms and therapeutic interventions
Xue Wen, Bohan Zhang, Beiyi Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 242
Xue Wen, Bohan Zhang, Beiyi Wu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 242
A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism
E. Grasset, Anthony Puel, J. Charpentier, et al.
Cell Metabolism (2017) Vol. 25, Iss. 5, pp. 1075-1090.e5
Open Access | Times Cited: 237
E. Grasset, Anthony Puel, J. Charpentier, et al.
Cell Metabolism (2017) Vol. 25, Iss. 5, pp. 1075-1090.e5
Open Access | Times Cited: 237
Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway
Paige V. Bauer, Frank A. Duca, T.M. Zaved Waise, et al.
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 101-117.e5
Open Access | Times Cited: 227
Paige V. Bauer, Frank A. Duca, T.M. Zaved Waise, et al.
Cell Metabolism (2017) Vol. 27, Iss. 1, pp. 101-117.e5
Open Access | Times Cited: 227
Role of the vagus nerve in the development and treatment of diet‐induced obesity
Guillaume de Lartigue
The Journal of Physiology (2016) Vol. 594, Iss. 20, pp. 5791-5815
Open Access | Times Cited: 214
Guillaume de Lartigue
The Journal of Physiology (2016) Vol. 594, Iss. 20, pp. 5791-5815
Open Access | Times Cited: 214
Enterochromaffin 5-HT cells – A major target for GLP-1 and gut microbial metabolites
Mari L. Lund, Kristoffer L. Egerod, Maja S. Engelstoft, et al.
Molecular Metabolism (2018) Vol. 11, pp. 70-83
Open Access | Times Cited: 209
Mari L. Lund, Kristoffer L. Egerod, Maja S. Engelstoft, et al.
Molecular Metabolism (2018) Vol. 11, pp. 70-83
Open Access | Times Cited: 209
Glucose transporters in the small intestine in health and disease
Hermann Koepsell
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 9, pp. 1207-1248
Open Access | Times Cited: 196
Hermann Koepsell
Pflügers Archiv - European Journal of Physiology (2020) Vol. 472, Iss. 9, pp. 1207-1248
Open Access | Times Cited: 196
Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation
Brent A. McLean, Chi Kin Wong, Jonathan E. Campbell, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 101-132
Open Access | Times Cited: 195
Brent A. McLean, Chi Kin Wong, Jonathan E. Campbell, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 101-132
Open Access | Times Cited: 195
Central and peripheral GLP-1 systems independently suppress eating
Daniel I. Brierley, Marie K. Holt, Arashdeep Singh, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 258-273
Open Access | Times Cited: 176
Daniel I. Brierley, Marie K. Holt, Arashdeep Singh, et al.
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 258-273
Open Access | Times Cited: 176
Metabolic Messengers: glucagon-like peptide 1
Fiona M. Gribble, Frank Reimann
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 142-148
Closed Access | Times Cited: 143
Fiona M. Gribble, Frank Reimann
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 142-148
Closed Access | Times Cited: 143
Role of the gut–brain axis in energy and glucose metabolism
Hallie Wachsmuth, Savanna N. Weninger, Frank A. Duca
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 377-392
Open Access | Times Cited: 129
Hallie Wachsmuth, Savanna N. Weninger, Frank A. Duca
Experimental & Molecular Medicine (2022) Vol. 54, Iss. 4, pp. 377-392
Open Access | Times Cited: 129
The metabolic impact of small intestinal nutrient sensing
Frank A. Duca, T.M. Zaved Waise, Willem T. Peppler, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 126
Frank A. Duca, T.M. Zaved Waise, Willem T. Peppler, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 126
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 114
Katherine O. Kopp, Elliot J. Glotfelty, Yazhou Li, et al.
Pharmacological Research (2022) Vol. 186, pp. 106550-106550
Open Access | Times Cited: 114
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 73
Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review
Manoj K. Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo
Pharmaceutical Research (2022) Vol. 39, Iss. 6, pp. 1233-1248
Open Access | Times Cited: 69
Manoj K. Mahapatra, Muthukumar Karuppasamy, Biswa Mohan Sahoo
Pharmaceutical Research (2022) Vol. 39, Iss. 6, pp. 1233-1248
Open Access | Times Cited: 69
Microbiota-gut-brain axis: relationships among the vagus nerve, gut microbiota, obesity, and diabetes
Susanna Longo, Stefano Rizza, Massimo Federici
Acta Diabetologica (2023) Vol. 60, Iss. 8, pp. 1007-1017
Open Access | Times Cited: 69
Susanna Longo, Stefano Rizza, Massimo Federici
Acta Diabetologica (2023) Vol. 60, Iss. 8, pp. 1007-1017
Open Access | Times Cited: 69
Dissociable hindbrain GLP1R circuits for satiety and aversion
Kuei-Pin Huang, Alisha A Acosta, Misgana Y. Ghidewon, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 585-593
Closed Access | Times Cited: 30
Kuei-Pin Huang, Alisha A Acosta, Misgana Y. Ghidewon, et al.
Nature (2024) Vol. 632, Iss. 8025, pp. 585-593
Closed Access | Times Cited: 30
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies
Cong Xie, Cong Qi, Jianwen Zhang, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116791-116791
Open Access | Times Cited: 2
Cong Xie, Cong Qi, Jianwen Zhang, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116791-116791
Open Access | Times Cited: 2
Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms
Kristoffer L. Egerod, Natalia Petersen, Pascal Timshel, et al.
Molecular Metabolism (2018) Vol. 12, pp. 62-75
Open Access | Times Cited: 157
Kristoffer L. Egerod, Natalia Petersen, Pascal Timshel, et al.
Molecular Metabolism (2018) Vol. 12, pp. 62-75
Open Access | Times Cited: 157